STAAR Surgical Company

NASDAQ (USD): STAAR Surgical Company (STAA)

Last Price

31.12

Today's Change

-0.08 (0.25%)

Day's Change

30.33 - 31.42

Trading Volume

753,116

Profile
STAA

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Thomas G. Frinzi Mr. Thomas G. Frinzi

Full Time Employees:  1,056 1,056

IPO Date:  1992-02-24 1992-02-24

CIK:  0000718937 0000718937

ISIN:  US8523123052 US8523123052

CUSIP:  852312305 852312305

Beta:  0.59 0.59

Last Dividend:  0.00 0.00

Dcf Diff:  -19.28 -19.28

Dcf:  50.40 50.40

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Address

25651 Atlantic Ocean Drive,
Lake Forest, CA 92630, US

626 303 7902

http://www.staar.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment